Blood Panel Could Tell COPD Apart From Asthma
Early research finds protein markers that distinguish COPD from asthma and smoking-related controls in a small study.
Updated on Nov. 3, 2026 in Asthma

Researchers have identified a panel of blood (serum) protein markers that can distinguish chronic obstructive pulmonary disease (COPD) from asthma, smoking, and non-smoking controls in a small laboratory study. The panel reached over 80% accuracy in a preliminary analysis, and the work is early-stage and has not yet been tested in larger, real-world patient populations.
Why it matters
COPD and asthma share overlapping symptoms, and smoking further complicates diagnosis, so a reliable blood-based test could help clinicians distinguish the conditions more accurately. Because the study tested the markers against asthma and smoking specifically, it addresses one of the main challenges in identifying COPD.
This was a small proteomic study of 40 serum samples, with 10 subjects each in COPD, asthma, smoker control, and non-smoker control groups. Logistic regression models using five-fold cross-validation reached over 80% accuracy for diagnosing COPD, but the sample size is small and the results remain preliminary.
The details
Researchers used label-free proteomics to measure more than 1,400 proteins in the blood serum of each participant and compared the patterns across the four groups. Five proteins stood out, with USP31, RNF10, and TACC2 distinguishing COPD from both control groups and asthma, and MAP3K10 and COL5A1 distinguishing COPD from healthy controls. Pathway analysis using the Reactome and PANTHER databases linked these proteins to biological processes involved in COPD, offering clues about the disease's underlying biology.
Health Landscape
COPD is often diagnosed late and is commonly confused with asthma, especially in people who smoke, which makes the search for objective blood-based markers a priority in respiratory medicine. This study adds to efforts to move COPD diagnosis toward biomarker panels that could complement spirometry and clinical assessment.
If you have a chronic cough, wheezing, or shortness of breath, especially if you smoke or have a history of asthma, it is worth discussing with your doctor which tests can help separate COPD from asthma. This research is preliminary, so it does not change current diagnostic practice, but it points toward more accurate testing in the future.
The takeaway
Distinguishing COPD from asthma remains difficult, and blood-based biomarkers may eventually help clinicians make that call more reliably. Until such tests are validated in larger studies, keep up regular respiratory checkups and bring any persistent breathing symptoms to your physician.
Further reading
For broader context on the respiratory conditions this research addresses, explore our Asthma coverage.
Source note: This article includes information reported by Nature.


